Additionally, healthy individuals were shown to have anti-GM-CSF AAbs at concentrations or in combinations that were non-neutralizing, whereas PAP patients generally had polyclonal antibodies at concentrations and titers that were capable of neutralizing the cytokine (5). The gene discussed is CSF2; the disease is pulmonary alveolar proteinosis.